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Dendritic  cells (DC) 1 are essential accessory cells for thymus-dependent anti- 
body  responses  (1).  Culture  systems  that  contain  DC  and  T  cells  generate  a 
lymphoproliferative  response  termed  the  syngeneic  mixed  leukocyte  reaction 
(syn  MLR)  (2).  There  is  evidence  that  syn  MLR-conditioned  media  contain 
interleukin  2 (IL-2) (T cell growth factor) (3-5) and helper factors for human B 
cell responses (6, 7). In this paper, we have used anti-IL-2 antibodies and purified 
IL-2 to describe how DC/T  cell-conditioned medium stimulates purified mouse 
B cells to develop into specific antibody-secreting cells.  A  three-step mechanism 
has been elucidated. The DC first induce T  cells to release and become responsive 
to IL-2 (5). The IL-2 then acts as the trigger for the production of helper factors. 
These factors finally act in concert with antigen to induce the antibody response. 
Materials and  Methods 
Mice.  6-10-wk-old mice of both sexes were purchased from the Trudeau  Institute, 
Saranac Lake, NY. The principal strains used, with similar results, were (DBA/2 × BALB/ 
c) F1 (H-2d×a),  B6.H-2k (H-2k).and Swiss ICR (H-2  s, most likely, according to cytotoxicity 
studies [unpublished] with a panel of anti-H-2 K, I, and D alloantisera). 
Antibodies.  Monoclonal antibodies 33D1  anti~DC  (8, 9),  B21-2 anti-I-A  b'd's (10),  TIB- 
99 anti-Thy-1.2 (11 ), and anti-Lyt-1.2 (12) were used as culture supernatants to selectively 
eliminate DC, Ia  + cells, and T cells, respectively, with rabbit complement (C*), as described 
(9). An Ig fraction of B21-2 was also added to cultures at 10 #g/ml to block the production 
of helper factors. Anti-Ia  k alloantibodies (A.TH anti-A.TL) were obtained from Accurate 
Chemical  &  Scientific  Corp.,  Hicksville,  NY,  while  anti-Ia  d (B10.LG  ×  A.TFR  anti- 
B10.D2), anti-K  k (A.TL ×  129 anti-A.AL), and anti-D  k [B10.A(2R) × C3H.SW anti-C3H] 
antibodies were provided by Dr. John  Ray, Research Resources Branch of the NIH. A 
rabbit anti-IL-2 antiserum was prepared by one of us (A.  G.-P.) as detailed below and 
added as a purified Ig fraction at 25 and 75 t~g/ml. 
lnterleukin  2.  IL-2 was purified  from the  supernatants  of concanavalin  A  (Con  A)- 
stimulated spleen cells as described (13). In a bioassay with Con A-stimulated spleen cells 
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as responders (13), the purified IL-2 was active at  I0  -~  M and saturated at  10 -9 M.  In 
this paper, the IL-2 was used at  1.5  x  10 -9 M.  The IL-2 preparation (fraction VI;  13) 
contained a single 23 kD polypeptide on sodium dodecyl sulfate-polyacrylamide gels, and 
had no detectable interferon (A. G.-P, manuscript in preparation) or B cell-stimulating 
activity  (see  Results).  Anti-IL-2  antibodies  were  prepared  by  injecting  three  rabbits 
intradermaily with  1-10 #g of purified IL-2 mixed 1:1  with AluGel, every 4 wk. An Ig 
fraction was obtained from protein A-Sepharose columns (Pharmacia, Inc., Piscataway, 
NJ). The antibody progressively neutralized IL-2 activity over a dose range of 2-80 #g/ 
ml (A. G.-P., manuscript in preparation). When coupled to cyanogen bromide-activated 
Sepharose 4B (Pharmacia, Inc.), the anti-IL-2 totally removed IL-2 activity from T  cell- 
conditioned media. A major 23 kD band could be eluted from the anti-IL-2 column with 
glycine  at  pH  2.8.  The  antibody  did  not  react  with  immune  interferon,  IL-1,  IL-3, 
cytolytic factor (manuscript in preparation), or B cell-stimulating factors (this paper). 
Cells.  DC  were  low  density  spleen  adherent  cells  depleted  of macrophages  by  a 
readherence method  (2).  DC-depleted  B/T lymphocyte mixtures were Sephadex G10. 
nonadherent  spleen  cells (14).  B cells were G10-nonadherent  spleen  cells treated with 
anti-Thy-l.2 and  with  anti-Lyt-l.2 and  C*.  T  cells  were largely eliminated,  since  the 
purified B cells did not proliferate to the T cell mitogen Con A and did not form antibody- 
secreting cells in response to DC (not shown). T cells were nylon wool-nonadherent spleen 
and lymph node cells (2).  In many cases, high density spleen cells (80-90%  of spleen), 
rather than whole spleen, were used to prepare B and T  lymphocytes. 
Syngeneic Mixed Leukocyte Reactions.  Syn MLR were generated by culturing 2-3 x  104 
DC and 5  ×  106 T  cells in  1-1.5  ml culture  medium (RPMI  1640  supplemented with 
10% fetal calf serum (FCS),  20 #g/ml gentamycin sulfate, 5 x  10  -5 M 2-mercaptoethanol) 
in 16-mm diam culture wells. Medium was collected, as a source of lymphokines, generally 
from day 0-4 or 2-4 cultures. Previous studies (2) have shown that most of the DC and 
responding T  cells in syn MLR cultures cluster together to form discrete aggregates. In 
this paper, we purified the aggregates by sedimentation at  100 g at 4"C for 10 min on 
10-ml Percoll gradients generated with a mixture of 4 parts Isoperc (Pharmacia, Inc.), 3 
parts FCS,  and  5.7  parts phosphate-buffered saline.  Cells from 6-12,  day 2  syn MLR 
cultures were sedimented on each 10-ml column. Clusters and nonclusters were separated 
by >5 ml on the column and were harvested with Pasteur pipettes. The fractions were 
washed twice in medium and maintained in culture at doses of 1.5-3 x  105 clusters and 
3 X 106 nonclusters per 16-mm diam well, which were doses that provided optimal levels 
of helper  factor per plated  cell.  In  some cases,  the  cell  fractions were  processed for 
transmission electron microscopy as described (2). 
Plaque Assay.  Antibody-forming cells were enumerated with a  direct plaque assay in 
agarose as described (I 4). 
Assay for B Cell Helper Factors.  2-3 ×  106 purified B cells were cultured for 4 d in  16- 
mm diam wells in  1 ml of 0,  12.5, 25, or 50% voi/vol, syn MLR-conditioned medium, as 
a  source of helper factors, with or without  3  x  10  ~ erythrocytes as antigen  (sheep or 
horse; Colorado Serum Co.,  Denver, CO).  In the presence of both antigen and helper 
factors, direct plaque-forming cells (PFC) began to appear at day 2-3 and peaked at day 
4. 
Proliferative Assays.  For the syn MLR, 50 #1 of a  1-mi culture was exposed in quadru- 
plicate for 4-18 h to [3H]thymidine (6.0 Ci/mM; Schwartz-Mann Div., Becton, Dickinson 
& Co., Orangeburg,  NY) at 4 #Ci/ml in 0.1  ml total volume. For the IL-2 bioassay, 2 x 
104 Con A-stimulated spleen cells (13) were exposed to graded doses of test media (6- 
50%  vol/vol) in  0.1  ml and pulsed with  [3H]thymidine at  14 #Ci/ml at  18-22  h.  IL-2 
activity was recorded as cpm uptake above background (no IL-2) under conditions where 
uptake was directly proportional to the dose of test medium. 
Results 
The  development  of  B  lymphocytes  into  antibody-secreting  cells  or  PFC 
requires  DC  and  T  cells (1).  It is  known  that  small  numbers  of DC  (1/200  T 2042  INTERLEUK1N  2  INDUCES  RELEASE  OF  B  CELL  HELPER  FACTORS 
TABLE  I 
Helper Factors  for Antibody Responses Are Produced by DC-T Cell Co-cultures 
Exp.  Source of helper factor (concentration) 
Antibody response (PFC) to: 
No RBC  SRBC  HRBC 
Anti-  Anti-  Anti-  Anti-  Anti-  Anti- 
SRBC  HRBC  SRBC  HRBC  SRBC  HRBC 
None  0  8  0  0  0  8 
Medium (50% vol/vol) from 3 X 104  0  0  0  0  0  4 
DC 
Medium (50% vol/vol) from 5 ×  106  0  4  4  0  0  0 
T  cells 
DC +  T  co-culture medium (50%  4  12  1,184  8  12  1,180 
vol/vol) 
None  0  0  0  0  0  0 
DC +  T  co-culture medium 
(50% vol/vol)  40  0  6,117  17  60  5,867 
(25% vol/vol)  60  3  4,153  0  10  1,890 
Culture supernatants from DC, T, or DC/T cell co-cultures were collected and added to 2  X  106 
purified B cells with or without erythocytes (RBC) as antigen. Direct PFC were measured 4 d  later 
using sheep (SRBC) or horse (HRBC) erythrocytes in the plaque assay. 
cells) induce a syn MLR (2).  We will first present data indicating that syn MLR 
media are  an  active  source  of helper  factor  for  specific antibody  responses, 
bypassing the need for intact DC and T  cells. Then we will characterize some of 
the requirements for the production and activity of helper factors,' particularly 
the contribution of IL-2. 
DC-T Cell Co-cultures Release B  Cell Helper Factors.  Syn MLR media (1  DC/ 
200 T  cells) reproducibly stimulated purified B cells to generate PFC to heter- 
ologous  erythrocytes (Table  I).  The  responses  were  antigen  dependent  and 
specific.  DC  alone  or  T  cells alone  produced little  or  no  factor.  Under our 
culture conditions, the syn MLR media were most active when taken from day 
2-4 of the MLR culture and were weak or inactive when taken from day 0-2 or 
4-6 (not shown). The helper factors were not genetically restricted, since factors 
produced by cells of one H-2 (H-2 k, s, or d) were active on B cells from syngeneic 
or allogeneic strains (Table II). 
The essential role of DC in inducing the release of B cell-stimulating factors 
was evaluated by selective depletion experiments with the 33D1 anti-DC antibody 
and C*. DC-depleted spleen cells or spleen-adherent cells would not trigger the 
syn MLR, as monitored by T  cell proliferation and release of IL-2 and helper 
factors (Table  III).  We conclude that  DC/T  cell co-cultures release soluble  B 
cell-stimulating factors  that  induce differentiation to  PFC  in  the  presence of 
antigen. 
Need for DC-T Cell Aggregates and Ia Antigens in Helper Factor Release.  Previous 
studies (2),  using cytology and [3H]thymidine labeling,  indicated that  DC and 
responding T  cells aggregated during the syn MLR to form distinctive clusters 
that could be separated by velocity sedimentation. Here we isolated cluster and 
noncluster fractions from day 2 syn MLR cultures. Recovery was 50-70% of the INABA  ET  AL.  2043 
TABLE II 
Syngeneic MLR Helper Factors Stimulate Syngeneic or Allogeneic B Cells 
Strain (H-2)  PFC response to doses of 
supernatant 
DC/T cell supernatant  B cells  None  25%  50% 
(DBA/2 × BALB/c) Fj 
(H-2 d × d) 
(DBA/2 × BALB/c) F~  0  4,153  6,117 
0  136  1,184 
0  816  4,520 
0  1,120"  -- 
Swiss (H-2')  0  --  5,164 
0  --  3,166 
B6.H-2k (H-2  k)  0  1,760  4,870 
Swiss (H-2  s)  Swiss  0  958 
B6.H2k  0  500*  1,644 
27  341 
(DBA/2 × BALB/c) FI  0  2,864  2,860 
0  2,304  3,008 
0  147"  1,070 
0  2,320  4,192 
Syn MLR supernatants were obtained from 4-<t DC/T cell co-cultures and added at 0, 25, or 50% 
vol/vol to purified B cells in the presence of SRBC. PFC were measured 4 d later. In the absence 
of SRBC, PFC yields were 0-5% of those shown. 
* In these three experiments,  supernatant  at a dose of 25% vol/vol was also  tested on 5 x  106 B/T 
lymphocyte mixtures (DC-depleted, Sephadex G10 nonadherent spleen) in addition to B cells. In 
the order of their appearance in table, their PFC were 1,010,704,  and 773. 
applied cells, and the aggregates represented  5-10% of total recovered cells. By 
Giemsa staining  and  transmission  electron  microscopy, >90%  of the  clustered 
cells were  lymphoblasts as compared with  5%  of the  nonclusters.  >80-90%  of 
the clustered cells could be killed with anti-Thy-1  or anti-Lyt-1 and C*. 
When  tested  for the production  of B  cell helper  factors,  the cluster fraction 
was  exclusively  active even  though  10  times  as  many nonclustered  cells  were 
evaluated  (Table  IV).  The  medium  conditioned  by  clusters  was  50-100%  as 
active as the  medium  from cluster-noncluster  mixtures.  The clusters were also 
the principal source of T  cell growth factor or IL-2 (Table IV), which is known 
to be released in the syn MLR (3-5). 
The addition  of specific anti-Ia antibodies,  but  not mixtures of anti-H-2K or 
D  reagents,  blocked  the  release  of helper  factors  from  preformed  DC/T  cell 
clusters  (Table  V).  Anti-Ia  also  blocked  T  cell  proliferation  and  IL-2  release 
(Table V). The anti-Ia antibodies probably interfered with T  cell recognition of 
DC Ia antigens, since most T  cells in the syn MLR are I-restricted (15) and since 
>90%  of the clustered cells were neither stained (indirect immunofluorescence) 
nor killed (C*) with anti-Ia antibodies (not shown). 
The addition  of anti-IE-2 antibodies  to  the  cluster cultures also ablated  the 
helper activity of the  conditioned  medium (Table VI).  Unlike the experiments 2044  INTERLEUKIN  2  INDUCES  RELEASE  OF  B  CELL  HELPER  FACTORS 
TABLE  III 
DC Requirement for Stimulating  T Cell Proliferation and Lymphokine 
Production in the syn MLR 
Stimulators  Activity in 
T  cell  supernatant 
Anti-DC  growth  Helper 
Treated cells  MAb/C*  IL-2  factor 
Whole spleen 
Adherent spleen cells 
cpm  cpm  PFC 
-/-  4,123  12,607  264 
+/-  5,300  13,328  260 
-/+  4,147  14,851  280 
+/+  1,765  1,665  0 
-/-  7,198  5,310  296 
+/-  6,619  10,929  316 
-/+  7,570  17,320  252 
+/+  2,081  2,349  0 
None  -/-  1,270  2,828  8 
Spleen cells (2.5 x  106) or spleen-adherent cells (5 X 104) from (D2 x  C) FI mice 
were irradiate,cL and  treated  with or without (+/-)  33D1  anti-DC monoclonal 
antibody (MAb) and rabbit complement (C*) as described (9). The treated cells 
were washed  and  used as stimulators of 4  x  106 responder  T  cells in  1.5  ml 
medium. At day 4, 50-~1 aliquots of the cell suspensions were taken for measure- 
ments of T  cell growth (cpm [aH]thymidine uptake).  The culture media were 
also assayed in graded doses (50% vol/vol is shown) for IL-2 (cpm [SH]thymidine 
uptake; background,  1,000 cpm) or helper factor (PFC response by purified B 
cells in the presence of sheep erythrocytes). Stimulator cells cultured alone did 
not release IL-2 or helper factor (not shown). 
TABLE  IV 
DC/T Cell Clusters Produce B Cell Helper Factors and IL-2 
Exp. 
Helper factor (PFC) 
Cells  IL-2 
50%  25%  12.5% 
cpm 
syn MLR clusters, 3 ×  106  1,328  616  212  16,809 
syn MLR nonclusters, 3 x  106  0  0  0  173 
Mix nonclusters +  3 ×  10  ~ clusters  1,984  796  176  19,939 
Mix nonclusters +  1.5 x  106 clusters  868  216  12  17,847 
syn MLR clusters, 3 x  105  4,112  3,416  2,816  158,242 
syn MLR nonclusters, 3 X 10 ~  0  0  0  11,014 
syn MLR, unseparated  2 x  106  3,008  2,304  1,552  182,147 
Cultured T  cells only 2 ×  106  424  20  12  Not done 
2.5 ×  104 DC and 5 x  106 T  cells were cultured for 2 d and separated into cluster and noncluster 
fractions. Each fraction was cultured an additional 2 d to provide conditioned media that were tested 
for B cell helper activity (PFC response to sheep erythrocytes with varying doses of medium) and IL- 
2 or T  cell growth factor (growth on Con A-stimulated spleen cells;  only the 50% dose is shown). 
The distinction between cluster and noncluster fractions that is shown here was repeated in six of six 
additional experiments described in subsequent tables. INABA  ET  AL. 
TABLE  V 
Anti-Ia Antibodies Inhibit Lymphokine Release  from DC/T Cell Clusters 
2045 
Helper factor (PFC) 
Cells  Alloantibody  Growth  I L-2 
50%  25%  12.5% 
cpm  cpm 
H-2k 
T  cells only  --  0  0  0  1,357  2,338 
Clusters 
Nonclusters 
--  964  511  180  22,606  226,706 
Anti-la  k,  1%  36  44  4  7,220  8,211 
Anti-Ia  k, 0.5%  11  36  12  14,046  10,334 
Anti-K,D  k,  1% each  984  640  132  23,058  194,841 
Anti-K,D  ~, 0.5% each  1,064  676  168  18,618  178,915 
--  24  8  0  1,549  13,886 
Anti-Ia  k,  1%  16  12  4  1,413  11,379 
--  1,136  696  220  11,315  211,713 
Anti-Ia  k,  1%  1,464  1,052  220  11,243  221,585 
Anti-la  k, 0.5%  1,332  620  184  11,788  211,836 
Anti-K,D  k,  1% each  1,028  644  204  14,423  91,598 
Anti-K,D  k, 0.5% each  1,512  644  184  14,664  169,973 
H-2s 
Clusters 
Nonclusters  --  44  20  12  1,369  11,031 
Anti-Ia  k, 1%  24  20  4  1,579  10,421 
B6.H2k and Swiss (H-2s) DC and T  cells (1:200) were co-cultured for 2 d and separated into cluster 
(10% of total cells) and noncluster fractions by velocity sedimentation. The fractions were cultured 
an additional  2 d with or without alloantibodies that react with H-2  k (I  k, K ~, and Dk; see Materials 
and Methods) but not with H-2'.  Proliferative activity (growth) was measured as in Table III. B cell 
helper activity was tested on Swiss B cells, which did not react with the alloantibodies. IL-2 data are 
shown for the 50% vol/vol dose; background was 2,700 cpm. The capacity of anti-Ia  k or monoclonal 
B21-2 (anti-Ia  b'd's) to block lymphokine release was repeated in five of five additional experiments, 
many of which are included in subsequent tables. 
with anti-Ia above (Table V), we could not determine if the anti-IL-2 was blocking 
the activity of helper factors in the B cell assay as has been reported (16,  17) or 
the production of factors in the DC/T cell culture. Therefore, we did two types 
of experiments  with  the rabbit anti-IL-2  reagent  to determine  if IL-2  made a 
direct contribution to PFC development. 
Evidence  that IL-2 Is Not a B  Cell Helper Factor.  First,  syn  MLR  media were 
passed over control  (Sepharose  preimmune  Ig) and anti-IL-2  columns (Fig.  1). 
IL-2 was found entirely in the effluent fraction of the control column and in the 
acid eluate of the anti-IL-2 column, with 30-70% recovery of total activity from 
both columns. Yet the effluents of both columns were exclusively and similarly 
active as a source of helper factor (Fig.  1). Therefore, anti-IL-2 does not absorb 
B cell helper factors. 
In the second approach,  we made use of the fact that the anti-IL-2  antibody 
neutralized 90-100%  of the I L-2 present in syn MLR (e.g., Table VI) and other 
T  cell-conditioned  (A.  G.-P.,  manuscript in preparation)  media.  However,  the 
anti-IL-2  did not neutralize  B  cell  helper activity using purified B  cells or DC- 2046  INTERLEUKIN  2  INDUCES  RELEASE  OF  B  CELL  HELPER  FACTORS 
TABLE  VI 
Anti-IL-2 Reduces Helper Activity in Medium Conditioned by DC/T Clusters 
Exp.  Antibody added to DC-T cell culture 
PFC response 
50%  25%  12.5% 
IL-2 
cpm 
(D2 × C) F~ (H-2  d) 
None  1,816  804  224 
Anti-lL-2, 80 ~g/ml  0  0  0  Not 
Anti-IA, B21-2,  10 #g/ml  4  0  0  tested 
(D2 x  C) Fl (H-2  d) 
None  1,712  388  50  87,846 
Anti-IL-2, 75 pg/ml  272  20  8  2,811 
25 ug/ml  316  8  0  7,741 
Anti-IA, B21-2,  10 t~g/ml  4  0  0  20,286 
Anti-I  d, 1% vol/vol  144  32  0  33,321 
0.5% vol/vol  276  8  4  47,150 
C3H (H-2  k) 
None  1,440  460  148  6,779 
Anti-IL-2, 75 pg/ml  0  0  4  235 
25 ~g/ml  72  16  8  349 
Control lg, 75 tag/ml  1,208  424  112  6,529 
25 pg/ml  1,388  468  120  6,479 
Anti-IA, B21-2, 10 ug/ml  1,276  472  116  9,404 
Anti-Ia  k,  1% vol/vol  108  28  4  1,066 
(D2 × C) Fl (H-2  d) 
None  1,328  616  212  15,167 
Anti-IL-2, 75 #g/ml  0  0  0  100 
25 ug/ml  0  0  0  738 
Control Ig, 75 #g/ml  1,132  604  190  10,772 
25 pg/ml  1,676  620  200  10,675 
2 d after the onset of the syn MLR (1  DC/200 T  cells),  aggregates of DC and responding T  cells 
were isolated and cultured an additional 2 d with or without anti-IL-2 or anti-Ia antibodies (the B21- 
2 monoclonal reacts with H-2  d as in experiments 1, 2, and 4 but not H-2  k, as in experiment 3). The 
supernatants  were collected and tested for helper activity on B cells from a  haplotype (H-2 k or s) 
that did not react with the anti-la antibody added  to the DC/T cell cultures.  IL-2 was assayed on 
Con A-stimulated spleen cells from BALB/c mice (backgrounds  were 7,000,  400, and  500 cpm in 
experiments 2-4 and were subtracted; data are for media tested at 25% vol/vol). 
depleted B/T lymphocyte mixtures as responders (Table VII) even at limiting 
doses of syn MLR medium (not shown). In contrast, the same anti-IL-2 reagent 
markedly reduced the yield of helper factor in  DC/T cell cultures (Table VI) 
and the yield of PFC in cultures of DC, B, and T  lymphocytes (Table VII). We 
conclude that  factors distinct  from IL-2  mediate B  cell helper activity in  syn 
MLR supernatants. Instead, IL-2 seems essential for factor production. 
IL-2  Triggers  the  Production  of B  Cell-stimulating  Factors.  We  next evaluated 
several T  cell populations to document directly that T  cells could release helper 
factor upon the addition of purified IL-2  (see Materials and Methods).  DC/T 
cell clusters were a logical starting point but proved unsuitable, because the high 
constitutive release of helper factor (Tables IV-VI) could not be reduced >80% INABA  ET  AL.  2047 
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I  . 
B  16  0  B  16 
Froction 
Fraction 
Helper activity (PFC) 
50%  25%  12.5% 
Unseparated medium  2,524  1,208  380 
Effluent: control lg  2,252  652  220 
Eluate: control Ig  0  0  0 
Effluent: anti-IL-2  1,696  494  120 
Eluate: anti-I L-2  4  0  0 
Purified IL-2  8  8  4 
FIGURE  1.  10  ml of DC/T cell-conditioned medium were passed over Sepharose columns 
conjugated with preimmune Ig (Q) or anti-IL-2 Ig (x).  1-ml fractions were collected and 25- 
#1 aliquots assayed for IL-2 (cpm [3H]thymidine uptake). Then the columns were eluted with 
glycine buffer, pH 2.8 (arrow). The eluate fractions were immediately neutralized with Tris 
buffer and 5-~1 aliquots were assayed for IL-2. 
by  treatment  with  anti-Ia  antibodies  and  C*  (not  shown).  The  nonclustered 
fraction, in contrast, released little or no helper factor unless IL-2 was added to 
the culture (Table VIII). The purified IL-2 itself did not stimulate PFC devel- 
opment from B cells and did not induce helper factor release from T  cells that 
had been cultured in the absence of DC (Table VII and VIII). T  cells were the 
likely source of helper factor in the IL-2-stimulated nonclustered fraction, since 
factor production was not reduced after the elimination of trace DC and B cells 
with anti-Ia and C* (Table VIII). 
The  IL-2-responsive  cells  in  the  noncluster  fraction  presumably  arose  as 
progeny of lymphocytes that  were proliferating  in  DC/T  cell clusters.  Indeed, 
when clusters were isolated and returned to culture, nests of lymphoblasts were 
released over a  2-d interval.  These released blasts formed little  IL-2 or helper 
factor, indicating that the population was effectively depleted of DC (Table IX). 
When exposed to purified IL-2, the lymphoblasts proliferated and released large 
amounts of helper activity in spite of the small numbers of cells tested (1  ×  10 5 
per  16-mm diam well in Table IX vs.  3 ×  10  6 bulk nonclustered cells in Table 
VIII).  We conclude  that  DC/T  cell  aggregates  generate  lymphoblasts  that  in 
turn release helper factors upon the addition of IL-2. 
Although anti-Ia antibodies blocked the production of helper factor from DC/ 
T  cell clusters (Table V), anti-Ia did not reduce IL-2-initiated factor production 
significantly (Table X). We interpret these findings to mean that recognition of 
Ia is needed to trigger the release of IL-2, but then the IL-2 acts directly on T 
cells to release helper factor. 
Evidence  that  IL-2  Is  the  Immediate  Stimulus for  Helper  Factor  Release.  Two 
observations were made which indicated that IL-2 was directly stimulating helper 2048  INTERLEUKIN  2  INDUCES  RELEASE  OF  B  CELL  HELPER  FACTORS 
TABLE  VII 
Effects of Anti-IL-2 on PFC Responses Mediated by DC or Helper Factors 
Components of culture during the generation  PFC 
of PFC responses  No. ofexp'ts  (percent of control) 
2 X l06 B cells + syn MLR medium (control) 
Plus anti-IL-2, 75 #g]ml 
Plus anti-IL-2, 25 #g/ml 
Plus pre-Ig, 75 #g/ml 
Plus pre-Ig, 25 #g/ml 
2 x  106 B cells only 
2 x  l06 B cells + pure IL-2 
5 x  l06 B/T cells + syn MLR medium (control) 
Plus anti-IL-2, 75 #g/ml 
Plus anti-IL-2, 25 #g/ml 
Plus pre-Ig, 75 t~g/ml 
Plus pre-Ig, 25 ~g/ml 
6  100 
6  86+9 
4  93 ± 20 
6  101 _  16 
4  109 + 28 
6  0 
3  0 
3  100 
3  115 ±  15 
1  104 
3  101 ± 27 
I  117 
5 x  106 B/T cells only  3  0 
5 ×  l06 B/T cells + pure IL-2  3  1 
5 x  106 B/T cells + 2.5 x  104 DC (control)  3  100 
Plus anti-IL-2, 75 ug/ml  3  24 ±  17 
Plus anti-IL-2, 25 t~g/ml  2  50 _+ 21 
Plus pre-Ig, 75 #g/ml  3  97 + 8 
Plus pre-Ig, 25 t~g/ml  2  102 _+ 7 
4-d anti-SRBC responses were generated by adding syn MLR supernatants to purified B cells or B/ 
T  cell mixtures, or by adding DC to B/T cell mixtures (Sephadex G10-nonadherent spleen).  The 
contribution of IL-2 to the PFC responses was evaluated by adding purified IL-2 (1.5 x  10  -9 M) or 
either a  neutralizing rabbit anti-IL-2 or control preimmune Ig (pre-Ig) at 75  or 25  #g/ml.  PFC 
responses are given as the mean + SD relative to the control (100%),  which was 2,816 (B cells + syn 
MLR medium), 976 (B/T cells + syn MLR medium), and 1,081 (DC + B/T cells). Responses in the 
absence of SRBC  were  0-2%  of the  responses in  the presence of SRBC.  In two of the above 
experiments, antibody neutralization of IL-2 was confirmed with a bioassay and shown  to be 95- 
100%. 
factor  production,  rather  than  inducing  T  cell  growth  that  was  followed  by 
release of helper factor to some other  stimulus.  First, irradiated (1,500  rad) T 
cells released normal and often elevated amounts of helper factor in response to 
IL-2 (Table XI).  Second, the release of helper factor was rapid with high levels 
detectable  in  3  h  and  peak  levels in  6-12  h.  The  kinetics  were  similar using 
either normal or irradiated T  cells as IL-2 responders (Table XI). 
Since all the above studies on the release of helper factor were performed  with 
DC/T  cell co-cultures,  we verified that similar events occurred  in the presence 
of B  cells.  Cultures  of  DC  and  B/T  cell  mixtures  (G10-nonadherent  spleen) 
formed aggregates that contained all three cell types (manuscript in preparation). 
These  clusters  were  an  active  source  of lymphokines  (IL-2  and  helper  factor; 
Table  XII). The  nonclustered  fraction,  which  lacked DC,  contained  radioresis- 
tant  cells that  released  helper  factor  in  response  to  purified  IL-2  (Table  XII). 
The  production  of factor by both cluster or noncluster fractions was ablated by 
treatment with either anti-Thy-1 and C* (manuscript in preparation). Therefore, INABA  ET  AL. 
TABLE  VIII 
IL-2 Induces the Nonclustered Cells in the syn MLR to Release Helper Factor 
2049 
Cells and supplements  Growth  IL-2 
Helper factor (PFC) 
Exp. 1  Exp. 2  Exp. 3 
cpm  cpm 
syn MLR clusters, 3 x  105  7,913  109,974  1,712  1,816  1,368 
syn MLR nonclusters, 3 x  l0  s  987  21,121  0  4  0 
Plus IL-2  8,656  61,657  300  796  540 
Plus IL-2 plus anti-IL-2  3,027  2,168  44  --  -- 
la-negative nonclusters  402  166  0  0  0 
Plus IL-2  3,364  59,509  452  2,364  408 
Plus IL-2 plus anti-IL-2  984  3,843  116  --  156 
Plus IL-2 plus pre-Ig  2,949  47,041  436  --  -- 
Cultured T  cells only  --  --  --  24  4 
Plus IL-2  --  --  --  64  92 
1L-2 only  --  --  24  --  20 
2-d syn MLR cultures were separated into cluster and noncluster components  and each was cultured 
an additional 2  d  with or without IL-2 or anti-IL-2. Aliquots of the nonclustered cells were also 
treated with anti-Ia and complement before culture. The culture supernatants were then tested for 
helper activity. In experiment 1, cell growth and IL-2 (50% vol/vol; 6,000 cpm background) were 
measured as well. 
TABLE  IX 
IL-2-responsive  T Blasts Are Released by DC-T Cell Clusters 
Cells in culture 
Dui~a- 
Growth  IL-2  tion 
Helper factor (PFC) 
50%  25%  12.5% 
T  blasts only 
h  cpm  cpm 
9  7,798  2,207  4 
25  3,620  1,793  40 
T  blasts +  IL-2  9  11,658  8,677  2,744 
25  17,671  5,467  1,609 
T  blasts, l,500 tad  9  1,748  8  0 
25  1,026  0  12 
T  blasts, 1,500 rad +  IL-2  9  3,308  10,545  3,320 
25  2,042  10,597  2,776 
IL-2 only  25  --  10,211  36 
0  0 
24  0 
1,600  580 
676  136 
0  4 
8  4 
2,356  892 
1,500  384 
28  12 
DC/T cell aggregates were isolated at day 2 of the syn MLR and then cultured an additional 2 d. 
Nests of lymphoblasts developed around the clusters. The lymphoblasts and residual clusters were 
separated by velocity sedimentation. 105 lymphoblasts were recultured for 9 or 25 h with or without 
purified IL-2 in  1 ml medium. In some cases, the cells were irradiated with 1,500 tad immediately 
before culture. At each time, aliquots of the cells were assayed for [SH]thymidine uptake (cpm uptake 
at 9-15 or 25-31  h) and the supernatants were assayed for IL-2 (25% vol/vol; background of 600 
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TABLE  X 
Effects of Anti-la Antibodies on the Release of Helper Factor by DC/T Ceil Clusters or by IL-2- 
stimulated Nonclusters 
Helper factor (PFC) 
Exp.  Cells and supplements  50%  25%  12.5% 
vol/vol  vol/vol  vol/vol 
B6.H-2k 
Clusters, 3 ×  10  ~  580  384  292 
Plus anti-Ia  ~,  1%  32  20  8 
0.5%  100  8O  68 
0.25%  244  132  56 
Nonclusters, 3 ×  106  12  8  4 
Plus IL-2  1,004  432  228 
Plus IL-2 plus anti-la  k,  1%  936  436  168 
0.5%  900  424  132 
IL-2 only  24  8  4 
(D2 ×  C) Fz (H-2  d) 
Clusters, 3 ×  106  1,368  736  252 
Plus B21-2,  10 #g/ml  4  0  0 
Nonclusters, 3 ×  106  0  0  0 
Plus 1L-2  540  276  32 
Plus 1L-2 +  B21-2  360  170  1 
IL-2 only  20  8  4 
2-d syn MLR cultures were separated into cluster and noncluster fractions and each was cultured an 
additional 2  d as a source of B cell helper factor. As described above (Tables IV, V, VIII) clusters 
make helper factor "constitutively," while nonclusters require stimulation with IL-2. The test B cells 
in experiments  1 and 2  were from Swiss (H-2s) and B6.H-2k mice, respectively, and did not react 
with the anti-la antibodies added during the production of helper factors. 
in the presence or absence of B cells, DC stimulate the formation of T  cells that 
will release helper factor in response to IL-2. 
Discussion 
This paper describes one pathway whereby DC stimulate the development of 
antibody-secreting cells or PFC. Small numbers of purified DC trigger blastogen- 
esis in a  subpopulation of syngeneic T  lymphocytes (the syn MLR) (2).  IL-2 is 
released and the T  cells become IL-2 responsive, as shown previously by Austyn 
et al. (5). The IL-2 then stimulates the production of B cell helper factors, which 
act independently of DC, T  cells, and IL-2 to induce a PFC response. Three new 
points emerged from this study: 
The Syn MLR Is an Active  Source of Helper Factors for Antigen-specific Antibody 
Responses.  Previous studies in  man  have shown that  syn MLR media enhance 
responses to pokeweed mitogen (6) and induce some B cells to differentiate into 
plasma cells (7).  In  this paper,  DC/T cell-conditioned  media helped  murine  B 
cells develop primary, antigen-specific responses. Few PFC formed in the absence INABA  ET  AL.  2051 
TABLE  XI 
IL-2-induced Release of Helper Factor by Activated T Cells: Kinetics and Resistance to Ionizing 
Irradiation 
Helper factor (PFC) present at (h) 
Exp.  Cells and supplements  IL-2  Growth 
3  6  12  24  48 
cpm  cpm 
Nonclusters  0  0  0  0  --  1,222 
Plus IL-2  1,112  2,032  2,328  2,400  --  23,950 
1,500 rad  0  0  3  3  --  0  Not tested 
1,500 rad +  IL-2  2,092  2,576  2,972  3,032  --  6,052 
IL-2 only  --  --  52  --  14,392 
Nonclusters  ....  0  2,969  3,752 
Plus IL-2  --  344  536  1,032  280  11,532  36,819 
1,500 rad  ....  0  505  395 
1,500 rad +  IL-2  --  744  776  844  1,268  4,527  1,419 
IL-2 only  ....  56  32,804 
Nonclusters  --  0  0  24  404 
Plus IL-2  --  1,488  2,012  2,116  1,824 
1,500 rad  --  0  12  12  28 
1,500 rad +  IL-2  --  2,276  2,812  2,728  2,636 
IL-2 only  ....  68 
Not tested 
The noncluster component of 2-d syn MLR cultures was isolated and cultured with or without IL-2 
and 1,500 rad irradiation for 3-48 h. Aliquots of the culture medium were tested for helper activity 
at  the  times  indicated.  Cell  growth  and  IL-2  (25%  vol/vol;  background  of  1,000  cpm  in  all 
experiments) were also monitored in some experiments; data are shown for the last time points. 
TABLE  XII 
Production of Helper Factors  from Mixtures of DC, B, and T Cells 
Cells used to prepare factor 
Helper activity (PFC)  IL-2 (cpm) 
50%  25%  12.5%  50%  25%  12.5% 
G 10-nonadherent spleen  16  4  0  13,332  8,415  3,900 
DC only  0  0  0  0  0  0 
GI0 +  DC 
Clusters,  1,996  1,024  372  292,492  155,147  77,100 
Nonclusters  68  12  0  32,381  15,099  9,004 
Nonclusters +  IL-2  1,000  488  120  92,616  45,164  20,319 
Nonclusters, 1,500 rad,  2,276  642  212  86,472  40,981  26,071 
+  IL-2 
IL-2 only  4  4  0  162,402  81,568  37,903 
2.5  ×  104  DC  were cultured with 5  x  10  ~ Sephadex G10-nonadherent spleen (B/T  lymphocyte 
mixtures) for 2 d and the cultures were separated into cluster and noncluster fractions. The fractions 
were maintained another 2 d in vitro with or without purified IL-2. The supernatants were removed 
and tested at  12.5,  25, and 50%  vol/vol for B cell helper function and IL-2 (backgrounds were 0 
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of antigen (e.g., Table I). Thus, the murine syn MLR helper factors should not 
be considered as true polyclonal activators. Instead,  the factors probably act on 
B cells that have been selected and/or activated in vitro by the added antigen. 
The precise stimulus which triggers T  cell growth and lymphokine release in 
the  syn  MLR  is  not  known.  The  T  cells are  I  restricted  (15),  as  is  typical  of 
helper cells, but it is not clear if the T  cells recognize Ia or Ia plus some undefined 
"antigen." 
Syn  MLR  helper  factors  likely  are  similar  to  the  major  histocompatibility 
complex-nonrestricted factors that have been recovered previously from cultures 
stimulated with iectin, ailoantigen,  and specific antigen (18-23, reviewed in 24) 
and  which  include  such  moieties  as  B  cell  growth  and  B  cell  differentiation 
factors (25-29).  In our experience, media collected between day 2 and 4 of the 
syn MLR are similar in activity to media from T  cells stimulated with lectin and 
alloantigen for 24-48 h. Since DC and T  cells are necessary components of any 
T-dependent  PFC culture system, syn MLR helper factors would be present in 
the absence of additional  stimulation  with antigen  or mitogen.  It remains to be 
determined if syn MLR-conditioned medium contains a representative sample of 
all the factors which can activate B cells (reviewed in 24). For example, production 
of antigen-specific helper factors (e.g., 30, 31) might require the addition of the 
appropriate erythrocyte to the syn MLR culture. 
DC as the Principal Stimulator of the Syn MLR.  Removal of DC with a specific 
antibody and C* severely inhibited cell proliferation and lymphokine release in 
the  syn  MLR  (Table  III).  This  selective  depletion  approach  complemented 
previous experiments  in  which  DC were shown to be active stimulators of the 
syn MLR, in contrast to macrophages,  B cells, and T  cells (2). 
The specialized stimulatory capacity of DC was also manifested by the devel- 
opment of DC/T cell aggregates that contained the bulk of the T  cells involved 
in  helper  factor release  (Tables  IV,  V).  Clusters  did  not  form  if T  cells were 
cultured with splenic macrophages or B cells (not shown). Most syn MLR-reactive 
T  cells formed clusters during 2 d of co-culture with DC at a DC/T cell ratio of 
1:100;  i.e.,  the  addition  of  DC  to  the  noncluster  fraction  resulted  in  little 
additional cell aggregation.  Previous studies have shown that primed T  cells can 
bind to monolayers enriched in macrophages (32-36), leading to a reduction of 
antigen-responsive cells in the nonattached fraction. However, the data obtained 
with DC/T cell clusters seem decidedly different from the data on macrophage/ 
lymphocyte binding.  First,  the  DC/T cell clusters  were formed at a  ratio  of 1 
DC per 200 unprimed T cells, while macrophage/lymphocyte binding has usually 
been done at a  1:1  ratio.  Second, few small lymphocytes were noted in the syn 
MLR clusters even though  the clusters were bathed  in a  10-40-fold excess of 
small  cells.  Macrophage  monolayers have been reported  to bind a  majority of 
small, nonspecific cells accounting for 50% or more of the added inoculum (35, 
36).  Third,  the DC/T  cell aggregates exhibited most of the functional activity 
(proliferation,  production  of IL-2 and helper factors) in the cultures and,  on a 
per  cell  basis,  were  enriched  some  10-20-fold  relative  to  the  unfractionated 
culture (Table IV). Macrophage monolayers have been used to deplete antigen- 
primed T  cells, but it has been difficult to show that the bound lymphocytes are 
enriched in functional activity relative to the starting inoculum (e.g., 34, 35). We INABA  ET  AL.  2053 
suspect this is in part due to nonspecific sticking of small lymphocytes and in part 
due to the inability of macrophages to independently sustain T  cell proliferation. 
IL-2 as an Essential  Stimulus for the Release  of B  Cell Helper Factors.  A  priori, 
the IL-2 that is present in syn MLR-conditioned medium could influence anti- 
body responses in three ways: (a) IL-2 could act directly on the B cell as has been 
proposed  in  some studies  (16,  17)  but  not  in  others (28,  20);  (b)  IL-2  could 
promote T  cell growth, and then the growing T  cells would release helper factor 
in response to antigen or other stimuli, as is usually conceived; (c) IL-2, rather 
than antigen, Ia, or accessory cells, could trigger helper factor production. The 
latter proved to be the case. 
With respect to the possibility that IL-2 is itself a helper factor, we found that 
an anti-IL-2  antibody neither neutralized nor absorbed helper activity (Table 
VII, Fig.  1), and that purified IL-2 did not stimulate B cells or DC-depleted B/ 
T  cell mixtures (Tables VII-XII). The reported effects of IL-2 on B cells could 
represent contaminating factors in the IL-2 preparation, or possibly IL-2 trig- 
gered helper factor production by contaminating T  cells. 
Since our probes (anti-IL-2 and purified IL-2) did not act directly on the B 
cell helper assay, we could evaluate the contribution of IL-2 to the generation 
of helper activity from DC/T co-cultures. The anti-IL-2 markedly blocked the 
production of helper factor (Table VI), suggesting that most factor release was 
IL-2 dependent. Likewise, purified IL-2 stimulated factor release from T  cells 
that had been rendered IL-2  responsive by co-culture with DC (Tables VIII- 
XII). The best source of these T  cells was the population of lymphoblasts derived 
from the DC/T cell aggregates (Table IX).  10 ~ blasts released as much helper 
factor in  9  h  as did 5  ×  106 T  cells in a  4-d syn MLR or 5  ×  106 Con A- or 
alloantigen-stimulated spleen cells in 24-48 h (not shown). T  cell growth was not 
required, since IL-2 induced a rapid release of helper factor (most was released 
in 3-6 h) even if the T  cells were irradiated to inhibit growth. Most likely the 
IL-2 was acting on the T  cell directly, because the responding population was 
effectively depleted of DC and because anti-Ia antibodies did not block the IL-2 
effect (Table X). 
Therefore IL-2 is more than a T  cell growth factor. It is the trigger needed 
by the activated helper T  cell to express its functional potential. It is intriguing 
that even if T  cells are allowed to grow, IL-2 does not induce the release of more 
helper factor than is produced by irradiated T  cells (Table XI). Presumably, the 
lymphoblast has to encounter DC again before it can respond to IL-2 and release 
lymphokine a  second time.  Studies to  test this hypothesis are underway. We 
would predict that the functional potential of helper T  cells is limited once the 
cell leaves the DC-rich environment that exists in lymphoid tissues or in DC/T 
cell clusters. Since DC are scarce in certain exudates (37), an immigrating helper 
T  blast may only be able to exhibit a single round of IL-2-mediated lymphokine 
release and division after an encounter with antigen in the inflammatory site. 
Previous studies have shown that IL-2 triggers the release of another lympho- 
kine, immune interferon (38, 39). In lepromatous leprosy, there exists a defect 
in  immune interferon release that can be reversed by the combination of M. 
Leprae antigen and IL-2 (40).  These studies have not determined if accessory 
cells  or  T  cell  proliferation  are  needed for  IL-2-induced interferon release. 2054  INTERLEUKIN  2  INDUCES  RELEASE  OF  B  CELL  HELPER  FACTORS 
However, it is possible that there are helper T  cells which produce interferon in 
two stages similar to that seen for B cell helper factors, i.e., DC-mediated T  cell 
activation followed by IL-2-mediated lymphokine release. 
The studies of Austyn et ai.  (5) first demonstrated the importance of DC in 
inducing T  cell  responsiveness to  IL-2.  DC  were added  to  T  cells and  then 
removed at defined time intervals before the onset of DNA synthesis. The data 
indicated that after co-culture with DC, T cells could synthesize DNA in response 
to the IL-2 that had been released into the culture medium. The DC so tightly 
controlled I L-2 release and responsiveness that the addition of exogenous growth 
factor had no effect unless the DC were first eliminated with antibody and C*. 
Future experiments should clarify if IL-2  induces the release of lymphokines 
required for the development of other effector cells, e.g., interferon for activated 
macrophages and distinct differentiation factors for cytolytic T  cells.  However 
the data presented in the work of Austyn et al. (5) and this paper begin to explain 
the capacity of DC to induce such complex multicellular responses as cytolytic T 
cell formation (2, 41), contact sensitivity (42), antibody formation (1), and graft 
rejection (43). In each system, helper T  cells can respond to antigen and mediate 
the development of other effector cells.  We reason that DC are the physiologic 
stimulators of IL-2 responsiveness and that the latter underlies the subsequent 
release of helper lymphokines and  the formation of effector cells.  Thus,  the 
strategy of a helper T  cell response is not simply antigen-induced clonal expan- 
sion. Rather, antigen and DC induce IL-2 release and responsiveness, which then 
mediates the production of helper factors and effector cells in  the absence of 
additional T  cell growth. 
Summary 
Dendritic  cells (DC)  are essential  accessory cells for T-dependent antibody 
responses in culture (1).  We have outlined a three-stage mechanism to explain 
the capacity of DC  to  stimulate  primary antibody responses  to  heterologous 
erythrocytes. First, DC induced T  cells to produce and to become responsive to 
interleukin 2 (IL-2). This stage corresponded to the syngeneic mixed leukocyte 
reaction (2) and involved the clustering of DC and T cells into discrete aggregates. 
Isolated clusters, representing 5-10% of the culture, were critical for IL-2 release 
and the production of IL-2-responsive T  blasts. In the second stage, IL-2 directly 
triggered the responsive T  cells to release B cell helper factors. This role for IL- 
2  was documented with a  rabbit anti-IL-2 reagent, purified IL-2, and T  cells 
that had been rendered IL-2 responsive by an initial co-culture with DC. T  cell 
growth was not required for IL-2-mediated helper factor release, since irradiated 
and untreated responders produced similar levels of factor and did so within 3 
h  of the  addition  of IL-2.  In  the  final  stage,  helper  factors  stimulated  the 
development of antibody-secreting cells from purified B lymphocytes. The helper 
factors were not H-2 restricted, but for both sheep and horse erythrocytes, the 
response  to  factors  was  antigen  dependent and  specific.  The  IL-2  that  was 
present in the DC/T cell-conditioned medium did not act on B cells, since helper 
activity  was  neither  neutralized  nor  absorbed  by  our  anti-IL-2  reagent.  We 
conclude that the ability of the DC to induce IL-2  release and responsiveness 
underlies its capacity to trigger both T  and B lymphocyte reactions. INABA  ET  AL.  2055 
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